Business UpdateJun 26, 2026, 08:46 AM
Nkarta to Present CAR-NK Cell Therapy Updates at H.C. Wainwright Conference
AI Summary
Nkarta, Inc., a clinical-stage biopharmaceutical company, announced its participation in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference. Nkarta President Nadir Mahmood will host a fireside chat on June 30th at 2 p.m. ET to provide updates on the company's investigational CAR-NK cell therapy for B cell-mediated autoimmune diseases. A live webcast and replay will be available on the company's investor relations website.
Key Highlights
- Nkarta to participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference.
- President Nadir Mahmood will host a fireside chat.
- Presentation scheduled for Tuesday, June 30th, at 2 p.m. ET.
- Will provide updates on investigational CAR-NK cell therapy.
- Therapy targets B cell-mediated autoimmune diseases.
- Webcast and replay will be available on Nkarta's investor website.
Price Impact
More from NKTX